E. Simons

发表

Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in two African settings: Lubumbashi, Democratic Republic of the Congo and Abidjan, Cote dIvoire

M. Diomande, F. Luquero, B. Nikolay, 2022, medRxiv.

Using Seroprevalence and Immunisation Coverage Data to Estimate the Global Burden of Congenital Rubella Syndrome, 1996-2010: A Systematic Review

C. Jackson, E. Vynnycky, F. Cutts, 2016, PloS one.

Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data

Abhijeet Anand, John Fricks, Emily Simons, 2012, The Lancet.

The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance.

N. Walker, E. Vynnycky, S. Goldie, 2013, Vaccine.

Global eradication of measles: an epidemiologic and economic evaluation.

Louis P Garrison, Colleen Burgess, Emily Simons, 2011, The Journal of infectious diseases.

Assessing the cost-effectiveness of measles elimination in Uganda: local impact of a global eradication program.

C. Bauch, L. Garrison, F. Braka, 2011, The Journal of infectious diseases.

Strategic planning for measles control: using data to inform optimal vaccination strategies.

Emily Simons, Molly Mort, P. Strebel, 2011, The Journal of infectious diseases.

Global measles mortality, 2000-2008.

Stephen L. Cochi, Emily Simons, Amra Uzicanin, 2009, MMWR. Morbidity and mortality weekly report.

Measles Eradication versus Measles Control: An Economic Analysis

A. Lefevre, D. Bishai, A. Dabbagh, 2014 .

The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda.

D. Bishai, J. Nabyonga-Orem, Emily A Simons, 2011, The Journal of infectious diseases.